Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-25T04:47:01.295Z Has data issue: false hasContentIssue false
  • English
  • Français

Protein Kinase C and Growth Regulation of Malignant Gliomas

Published online by Cambridge University Press:  18 September 2015

Gordon H. Baltuch ,
Nora P. Dooley ,
Jean-Guy Villemure  and
Voon Wee Yong
Gordon H. Baltuch
Affiliation:
Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montreal
Nora P. Dooley
Affiliation:
Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montreal
Jean-Guy Villemure
Affiliation:
Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montreal
Voon Wee Yong*
Affiliation:
Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montreal
*
Montreal Neurological Institute, 3801 University Street, Montreal, Quebec, Canada H3A 2B4
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

This article reviews the role of the signal transduction enzyme protein kinase C in the regulation of growth of malignant gliomas, and describes how targetting this enzyme clinically can provide a novel approach to glioma therapy.

Résumé

Résumé

Nous revoyons le rôle de l’enzyme de transduction du signal, la protéine kinase C, dans la régulation de la croissance des gliomes malins et nous décrivons comment le ciblage de cet enzyme peut fournir une approche nouvelle dans le traitement du gliome.

Type
Review Articles
Information
Canadian Journal of Neurological Sciences , Volume 22 , Issue 4 , November 1995 , pp. 264 - 271
Copyright
Copyright © Canadian Neurological Sciences Federation 1995

References

REFERENCES

1. Berens, ME, Rutka, JT, Rosenblum, ML. Brain tumour epidemiology, growth, and invasion. Neurosurg Clin Am 1990; 1: 1–18.Google Scholar
2. Zülch, KJ. Histological Typing of Tumors of the Central Nervous System. Geneva, World Health Organization, 1979.Google Scholar
3. Cavenee, WK, White, RL. The genetic basis of cancer. Sci Am March 1995; 72–79.CrossRefGoogle ScholarPubMed
4. Bello, MJ, de Campos, JM, Kusak, ME, et al. Ascertainment of chromosome 7 gains in malignant gliomas by cytogenetic and RFLP Analyses. Cancer Genet Cytogenet 1994; 72: 55–58.Google Scholar
5. Bello, MJ, de Campos, JM, Vaquero, J, et al. Molecular and cytogenetic analysis of chromosome 9 deletions in 75 malignant gliomas. Genes Chromosomes Cancer 1994; 9: 33–41.CrossRefGoogle ScholarPubMed
6. Collins, VP, James, CD. Genes and chromosomal alterations associated with the development of human gliomas. FASEB J 1993; 7: 926–930.Google Scholar
7. Cavenee, WK, Scrable, HJ, James, CD. Molecular genetics of human cancer predisposition and progression. Mutat Res 1991; 247: 199–202.Google Scholar
8. Louis, DN. The p53 gene and protein in human brain tumors. J Neuropathol Exp Neurol 1994; 53: 11–21.Google Scholar
9. Gillaspy, GE, Mapstone, TB, Samols, D, Goldthwait, DA. Transcriptional patterns of growth factors and proto-oncogenes in human glioblastomas and normal glial cells. Cancer Lett 1992; 65:55–60.Google Scholar
10. Arita, N, Hayakawa, T, Izumoto, S, et al. Epidermal growth factor receptors in human glioma. J Neurosurg 1989, 70: 916–919.Google Scholar
11. Fleming, TP, Saxena, A, Clark, WC, et al. Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res 1992; 52:4550–4553.Google Scholar
12. Gammeltoft, S, Ballotti, R, Kowalski, A, Westermark, B, Obberghen, EV. Expression of two types of receptor for insulin-like growth factors in human malignant glioma. Cancer Res 1988; 48: 1233–1237.Google ScholarPubMed
13. Morrison, RS, Giordano, S, Yamaguchi, , et al. Basic fibroblast growth factor expression is required for clonogenic growth of human glioma cells. J Neurosci Res 1993; 34: 502–509.Google Scholar
14. Batra, SK, Rasheed, BK, Bigner, SH, Bigner, DD. Biology of disease: oncogenes and anti-oncogenes in human central nervous system tumors. Lab Invest 1994; 71: 621–637.Google Scholar
15. Von Deimling, A, Eibl, RH, Ohgaki, H, et al. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res 1992; 52: 2987–2990.Google Scholar
16. Fults, D, Brockmeyer, D, Tullous, MW, Pedone, CA, Cawthon, RM. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 1992; 52: 674–679.Google Scholar
17. Sidransky, D, Mikkelsen, T, Schechleimer, K, et al. Clonal expression of p53 mutant cells is associated with brain tumour progression. Nature 1992; 355: 846–847.Google Scholar
18. El-Azouzi, M, Chung, RY, Farmer, GE, et al. Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas. Proc Nat Acad Sci USA 1989; 86: 7186–7190.Google Scholar
19. Lang, FF, Miller, DC, Koslow, M, Newcomb, EW. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 1994; 81:427–436.CrossRefGoogle ScholarPubMed
20. Cantley, LC, Auger, KR, Carpenter, C, et al. Oncogenes and signal transduction. Cell 1991; 64: 281–302.Google Scholar
21. Berra, E, Diaz-Meco, MT, Dominguez, I, et al. Protein kinase C ς isoform is critical for mitogenic signal transduction. Cell 1993; 74: 555–565.Google Scholar
22. Kolch, W, Heldecker, G, Kochs, G, et al. Protein kinase Ca activates RAF-1 by direct phosphorylation. Nature 1993; 364: 249–252.Google Scholar
23. Nishizuka, Y. Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992; 258: 607–613.Google Scholar
24. Hug, H, Sarre, TF. Protein kinase C isoenzymes: divergence in signal transduction? Biochem J 1993; 291: 329–343.CrossRefGoogle ScholarPubMed
25. Dekker, LV, Parker, PJ. Protein kinase C-a question of specificity. Trends Biol Sci 1994; 19: 73–77.Google Scholar
26. Selbie, LA, Scmitz-Peiffer, C, Sheng, Y, et al. Molecular cloning and characterization of PKC, an atypical isoform of protein kinase C derived from insulin secreting cells. J Biol Chem 268: 24296–24302.Google Scholar
27. Johannes, FJ, Prestle, J, Eis, S, et al. PKCμ is a novel, atypical member of the protein kinase C family. J Biol Chem 1994; 269: 6140–6148.Google Scholar
28. Mochly-Rosen, D, Khaner, H, Lopez, J. Identification of intracellular receptor proteins for activated protein kinase C. Proc Nat Acad Sci USA 1991; 88:3997–4000.Google Scholar
29. Berridge, MJ, Irvine, RF. Inositol phosphate, a novel second messenger in cellular signal transduction. Nature 1984; 312: 315–321.Google Scholar
30. Hannun, YA, Bell, RM. Aminoacridines, potent inhibitors of protein kinase C. J Biol Chem 1988; 263:5124–5131.Google Scholar
31. Basu, A. The potential of protein kinase C as a target for anticancer treatment. Pharmacol Ther 1993; 59: 257–280.Google Scholar
32. Wetsel, WC, Khan, WA, Merchethaler, I, et al. Tissue and cellular distribution of the extended family of protein kinase C isoenzymes. J Cell Biol 1992; 117: 121–133.CrossRefGoogle ScholarPubMed
33. Fletcher, DJ, Ways, DK. Age-dependent expression of protein kinase C isoforms in rat islets. Diabetes 1991; 40: 1496–1503.Google Scholar
34. Osborne, NN, Wood, J, Groome, N. The occurrence of three calciumindependent protein kinase C subspecies (δ, ε and ς) in the retina of different species. Brain Res 1994; 637: 156–160.Google Scholar
35. Castagna, M, Takai, Y, Kaibuchi, K, et al. Direct activation of calciumactivated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 1982; 257: 7847–7851.Google Scholar
36. Fleischman, LF, Chahwala, SB, Cantley, L. Ras-transformed cells: altered levels of phosphotidylinositol-4,5-biphosphate and catabolites. Science 1986; 231: 407–410.Google Scholar
37. O’Brian, CA, Liskamp, RM, Solomon, DH, Weinstein, IB. Inhibition of protein kinase C by tamoxifen. Cancer Res 1985; 45: 2462–2465.Google Scholar
38. Alvaro, V, Touraine, P, Vozari, RR, et al. Protein kinase C activity and expression in normal and adenomatous human pituitaries. Int J Cane 1992; 50:724–730.Google Scholar
39. Weinstein, IB. The role of protein kinase C in growth control and the concept of carcinogenesis as a progressive disorder in signal transduction. Adv Second Mess and Phosphoprot Res 1990; 24: 307–316.Google ScholarPubMed
40. Gopalakrishna, R, Barsky, SH. Tumor promotor-induced membranebound protein kinase C regulates hematogenous metastasis. Proc Natl Acad Sci 1988; 85:612–616.Google Scholar
41. Schwartz, GK, Redwood, SM, Ohnuma, T, et al. Inhibition of invasive human bladder carcinoma cells by protein kinase C inhibitor staurosporine. J Natl Cancer Inst 1990; 82: 1753–1756.Google Scholar
42. Blobe, GC, Sachs, CW, Khan, WA, et al. Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrugresistant MCF-7 cells. J Biol Chem 1993; 268: 658–664.Google Scholar
43. Huang, M, Chida, K, Kamata, N, et al. Enhancement of inositol phospholipid metabolism and activation of protein kinase C in ras-transformed rat fibroblasts. J Biol Chem 1988; 263: 17975–17980.Google Scholar
44. Borner, C. Guadagno, SN, Fabbro, D, Weinstein, IB. Expression of four protein kinase C isoforms in rat fibroblasts. J Biol Chem 1992; 267:12892–12899.Google Scholar
45. Delage, S, Chastre, E, Empereur, S, et al. Increased protein kinase C Ó expression in human colonic caco-2 cells after insertion of human Ha-ras or polyoma virus middle T oncogenes. Cancer Res 1993; 53:2762–2770.Google Scholar
46. Eldar, H, Zisman, Y, Ullrich, A, Livneh, E. Overexpression of protein kinase Cα-subtype in swiss/3T3 fibroblasts causes loss of both high and low affinity receptor numbers for epidermal growth factor. J Biol Chem 1990, 265: 13290–13296.Google Scholar
47. Gruber, JR, Ohno, S, Niles, RM. Increased expression of protein kinase Ca plays a key role in retinoic acid-induced melanoma differentiation. J Biol Chem 1992; 267: 13356–13360.Google Scholar
48. Housey, GM, Johnson, MD, Hsiao, WLW, et al. Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell 1988; 52: 343–354.Google Scholar
49. Choi, PM, Tchou-Wong K-M, Weinstein, B. Overexpression of protein kinase C in HT29 colon cancer cells causes growth inhibition and tumor suppression. Mol Cell Biol 1990; 10: 4650–4657.Google ScholarPubMed
50. Yamanishi, DT, Graham, M, Buckmeier, JA, Meykens, FL. The differential expression of protein kinase C genes in normal human neonatal melanocytes and metastatic melanomas. Carcinogenesis 1991; 12: 105–109.Google Scholar
51. Cacace, AM, Guadagno, SN, Krauss, RS, Fabbro, D, Weinstein, IB. The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene 1993; 8: 2095–2104.Google Scholar
52. Mischak, H, Goodnight, J, Kolch, W, et al. Overexpression of protein kinase C-δ and ε in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J Biol Chem 1993; 268: 6090–6096.Google Scholar
53. Tanaka, C, Nishizuka, Y. The protein kinase C family for neuronal signalling. Ann Rev Neurosci 1994; 17: 551–567.Google Scholar
54. Ben-Ari, Y, Anikszteijn, L, Bregestovski, P. Protein kinase C modulation of NMDA currents: an important link for LTP induction. Trends Neurosci 1992; 15: 333–339.Google Scholar
55. Roivainen, R, McMahon, T, Messing, RO. Protein kinase C isozymes that mediate enhancement of neurite outgrowth by ethanol and phorbol esters in PC 12 cells. Brain Res 1993; 624: 85–93.Google Scholar
56. O’Driscoll, KR, Teng, KK, Fabbro, D, Greene, LA, Weinstein, IB. Selective translocation of protein kinase C-8 in PC 12 cells during nerve growth factor-induced neuritogenesis. Mol Biol Cell 1995; 6: 449–458.Google Scholar
57. Yong, VW, Sekiguichi, S, Kim, MW, Kim, SU. Phorbol esters enhances morphological differentiation of oligodendrocytes in culture. J Neurosci Res 1988; 19: 187–194.Google Scholar
58. Yong, VW, Dooley, NP, Noble, PG. Protein kinase C in cultured adult human oligodendrocytes: a potential role for isoform a as a mediator of process outgrowth. J Neurosci Res 1994; 39: 83–96.CrossRefGoogle Scholar
59. Honegger, P. Protein kinase C-activating tumour promotors enhance the differentiation of astrocytes in aggregating fetal brain cell cultures. J Neurochem 1986; 46: 1561–1566.Google Scholar
60. Shafit-Zagardo, B, Kume-Iwaki, A, Goldman, JE. Astrocytes regulate GFAP mRNA levels by cyclic AMP and protein kinase C-dependent mechanisms. Glia 1988; 1: 346–354.Google Scholar
61. Mobley, PL, Scott, SL, Cruz, EG. Protein kinase C in astrocytes: a determinant of cell morphology. Brain Res 1986; 398: 366–369.CrossRefGoogle ScholarPubMed
62. Harrison, BC, Mobley, PL. Phorbol ester-induced change in astrocyte morphology: correlation with protein kinase C activation and protein phosphorylation. J Neurosci Res 1990; 25: 71–80.Google Scholar
63. Murphy, S, McCabe, N, Morrow, C, Pearce, B. Phorbol ester stimulates proliferation of astrocytes in primary culture. Dev Brain Res 1987; 31: 133–135.Google Scholar
64. Bhat, NR. Role of protein kinase C in glial cell proliferation. J Neurosci Res 1989; 22: 20–27.Google Scholar
65. Sawada, M, Suzumura, A, Ohno, K, Marunouchi, T. Regulation of astrocyte proliferation by prostaglandin E2 and the a subtype of protein kinase C. Brain Res 1993; 613: 67–73.Google Scholar
66. Yong, VW, Moumdjian, R, Yong, FP, et al. Gamma-interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo. Proc Natl Acad Sci USA 1991; 88:7016–7020.CrossRefGoogle ScholarPubMed
67. Yong, VW. Proliferation of human and mouse astrocytes in vitro: signalling through the protein kinase C pathway. J Neurol Sci 1992; 111:92–103.Google Scholar
68. Couldwell, WT, Uhm, JH, Antel, JP, Yong, VW. Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro. Neurosurg 1991; 29: 880–887.Google Scholar
69. Baltuch, GH, Dooley, NP, Couldwell, WT, Yong, VW. Staurosporine differentially inhibits glioma versus non-glioma cell lines. J NeuroOnc 1993; 16: 141–147.Google Scholar
70. Couldwell, WT, Antel, JP, Yong, VW. Protein kinase C activity correlates with the growth rate of malignant gliomas. II Effects of glioma mitogens and modulators of PKC. Neurosurg 1992; 31: 717–724.Google Scholar
71. Pollack, IF, Randall, MS, Kristofik, MP, et al. Effects of tamoxifen on DNA synthesis and proliferation of human glioma lines in vitro. Cancer Res 1990; 50: 7134–7138.Google Scholar
72. Baltuch, GH, Dooley, NP, Rostworowski, KM, Villemure, J-G, Yong, VW. Protein kinase C isoform a overexpression in C6 glioma and its role in cell proliferation. J NeuroOnc (in press).Google Scholar
73. Dooley, NP, Baltuch, GB, Paton, A, et al. Phosphorothioate antisense oligonucleotides to protein kinase Ca inhibit human glioma growth in vitro, submitted.Google Scholar
74. Reifenberger, G, Deckert, M, Wechsler, W. Immunohistochemical determination of protein kinase C expression and proliferative activity in human brain tumors. Acta Neuropathol 1989; 78: 166–175.Google Scholar
75. Todo, T, Shitara, N, Nakamura, H, Takakura, K, Ikeda, K. Immunohistochemical demonstration of protein kinase C isozymes in human brain tumours. Neurosurgery 1991; 108: 11–16.Google Scholar
76. Benzil, DL, Finkelstein, SD, Epstein, MH, Finch, PW. Expression pattern of a-protein kinase C in human astrocytomas indicates a role in malignant progression. Cancer Res 1992; 52: 2951–2956.Google Scholar
77. Raizada, MK, Morse, CA, Gonzales, RA, Crews, FT, Sumners, C. Receptors for phorbol esters are primarily localized in neurons: comparison of neuronal and glial cultures. Neurochem Res 1988; 13:51–56.Google Scholar
78. Saito, N, Kikkawa, U, Nishizuka, Y, Tanaka, C. Distribution of protein kinase C-like immunoreactive neurons in rat brain. J Neurosci 1988; 8:369–382.Google Scholar
79. Clark, EA, Leach, KS, Trojanowski, JQ, Lee, VM-Y. Characterization and differential distribution of the three major human protein kinase C isozymes (PKCa, PKCp\ and PKCy) of the central nervous system in normal and Alzheimer’s disease brains. Lab Invest 1991; 64:35–44.Google Scholar
80. Shimosawa, S, Hachiya, T, Hagiwara, M, et al. Type-specific expression of protein kinase C isozymes in human brain tumours. Neurosci Lett 1990; 108: 11–16.Google Scholar
81. Misra-Press, A, Fields, AP, Samols, D, Goldthwait, DA. Protein kinase C isoforms in human glioblastoma cells. Glia 1992; 6: 188–197.Google Scholar
82. Xiao, H, Goldthwait, DA, Mapstone, T. The identification of four protein kinase C isoforms in human glioblastoma cell lines: PKC alpha, gamma, epsilon, and zeta. J Neurosurg 1994; 81: 734–740.Google Scholar
83. Ahmad, S, Mineta, T, Martuza, RL, Glazer, RI. Antisense expression of protein kinase Cot inhibits the growth and tumourigenicity of human glioblastoma cells. Neurosurgery 1994; 35: 904–909.Google Scholar
84. Matsumoto, T, Tani, E, Yamaura, , et al. Effects of protein kinase C modulators on multidrug resistance in human glioma cells. Neurosurgery 1995; 36: 565–572.Google Scholar
85. Yong, VW, Antel, JP. Culture of glial cells from human brain biopsies. In: Federoff, S, Richardson, A, eds. Protocols for neural cell culture. St Louis: Humana Press, 1992: 81–96.Google Scholar
86. McConkey, DJ, Hartzell, P, Jondal, M, Orrenius, S. Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C. J Biol Chem 1989; 264: 13399–13402.Google Scholar
87. Jarvis, WD, Turner, AJ, Povirk, LF, Traylor, RS, Grant, S. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocyte leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res 1992; 54: 1707–1714.Google Scholar
88. Haimovitz-Friedman, A, Balaban, N, McLoughlin, M. et al. Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res 1994; 54:2591–2597.Google Scholar
89. Couldwell, WT, Hinton, DR, He, S, et al. Protein kinase inhibitors induce apoptosis in human malignant glioma lines. FEBS Lett 1994; 345:43–46.Google Scholar
90. Weller, M, Frei, K, Groscurth, P. et al. Anti-Fas/APO-1 antibodymediated apoptosis of cultured human glioma cells. J Clin Invest 1994; 94:954–964.Google Scholar
91. Uhm, JH, Dooley, NP, Villemure, J-G, Yong, VW. Glioma invasion requires a 72 kDa metalloprotease that is regulated by protein kinase C, submitted.Google Scholar
92. Chambers, TC, Pohl, J, Raynor, RL, et al. Identification of specific sites in human P-glycoprotein phosphorylated by protein kinase C. J Biol Chem 1993: 268: 4592–4595.Google Scholar
93. Zhang, W, Yamada, H, Sakai, N, Niikawa, S, Nozawa, Y. Enhancement of radiosensitivity by tamoxifen in C6 glioma cells. Neurosurgery 1992; 31:125–730.Google Scholar
94. Vertosick, FT, Selker, RG, Pollack, IF, et al. The treatment of intracranial malignant gliomas using orally administered tamoxifen therapy: preliminary results in a series of “failed” patients. Neurosurgery 1992: 30: 897–903.Google Scholar
95. Baltuch, GH, Couldwell, WT, Villemure, J-G. Yong, VW. Protein kinase C inhibitors suppress cell growth in established and low passage cell lines. A comparison between staurosporine and tamoxifen. Neurosurgery 1993; 33: 495–501.Google Scholar
96. Baltuch, GH, Shenouda, G, Langleben, A, Villemure, J-G. High dose tamoxifen in the treatment of recurrent high grade glioma: a report of clinical stabilization and tumour regression. Can J Neurol Sci 1993; 20: 168–170.Google Scholar
97. Couldwell, WT, Weiss, MH, DeGiorgio, CM, et al. Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen. Neurosurgery 1993: 32: 485–490.Google Scholar
98. Yong, VW, Tejada-Berges, T, Goodyer, CG, Antel, JP, Yong, FP. Differential proliferative response of human and mouse astrocytes to gamma-interferon. Glia 1992; 6: 269–280.Google Scholar